rapilysin
actavis group ptc ehf - retepláza - infarkt myokardu - antitrombotické činidlá - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
atorvastatin actavis 10 mg
actavis group ptc ehf., island - atorvastatín - 31 - hypolipidaemica
atorvastatin actavis 20 mg
actavis group ptc ehf., island - atorvastatín - 31 - hypolipidaemica
atorvastatin actavis 40 mg
actavis group ptc ehf., island - atorvastatín - 31 - hypolipidaemica
atorvastatin actavis 80 mg
actavis group ptc ehf., island - atorvastatín - 31 - hypolipidaemica
sindaxel
actavis group ptc ehf. - paklitaxel - 44 - cytostatica
perlinring
actavis group ptc ehf., island - vaginálne krúžky s progestínom a estrogénom - 17 - anticoncipientia
levofloxacin actavis 5 mg/ml
actavis group ptc ehf., island - levofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
abricef
actavis group ptc ehf., island - cefotaxím - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
sindronat 400 mg
actavis group ptc ehf. - kyselina klodrónová - 87 - varia i